Medicare Part D is the portion of Medicare that provides outpatient prescription drug coverage through private plans that contract with Medicare under federal standards. The benefit operates through plan enrollment rules, a covered-drug framework (a plan “formulary”), and member cost-sharing that varies by plan and by medication.

Plain-Language Summary: Medicare Part D is insurance for prescription medicines obtained at retail pharmacies or through mail-order services. Coverage and out-of-pocket costs vary because they depend on the specific plan’s drug list, pharmacy network, and cost-sharing design.

Context

Medicare Part D was established by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 and began in 2006. It expanded Medicare to include a broadly available outpatient prescription drug benefit, delivered through competing private plans rather than a single uniform government-administered drug plan.

Part D coverage is accessed in two main ways: (1) a stand-alone Prescription Drug Plan (PDP) for individuals enrolled in Original Medicare (Part A and Part B), or (2) a Medicare Advantage plan that includes drug coverage (often described as MA-PD). These arrangements differ in how medical and drug benefits are packaged, while the drug benefit is still governed by Part D program rules.

Part D plans generally publish a formulary, a list of covered drugs organized into tiers (for example, preferred generics, non-preferred brands, and specialty drugs). Plans may also apply utilization management requirements, such as prior authorization, quantity limits, or step therapy, which can affect whether a drug is covered immediately or under specified conditions.

Coverage is commonly network-based. Plans contract with “preferred” and “standard” pharmacies, and the amounts paid by plan members may differ depending on where prescriptions are filled. Some plans also use mail-order pharmacy services under plan-specific terms.

The typical cost structure includes a monthly premium, an annual deductible in many plans, and copayments or coinsurance that vary by drug tier. For higher-income beneficiaries, premiums may be affected by an income-related adjustment amount. Part D also includes a statutory benefit design with phases across the calendar year in which cost-sharing can change after spending reaches defined thresholds. These thresholds are set by law and are updated periodically, and the benefit phases reset each year.

Enrollment timing is governed by eligibility windows and related program rules. Program rules include a late-enrollment penalty concept when an individual lacks creditable prescription drug coverage for a specified period and later enrolls. The penalty framework, what counts as creditable coverage, and how gaps are measured are defined within the program’s regulations and related guidance.

Misunderstandings

A common misunderstanding is that Medicare Part D is automatic with Medicare. Part D generally requires enrollment in a specific plan, and plan-to-plan differences can result in different coverage terms for the same medication.

Another misunderstanding is equating “covered” with “low cost.” A drug may appear on a formulary yet still involve higher coinsurance, placement on a specialty tier, or restrictions such as prior authorization.

It is also sometimes assumed that coverage terms remain the same after enrollment. Plans can change formularies, tier placement, pharmacy networks, and cost-sharing from year to year within program rules, which can change how coverage operates even when the plan member’s health status is unchanged.

Finally, Part D is sometimes conflated with Part B drug coverage. Part B generally covers certain drugs administered in clinical settings (including many infused or injectable drugs), while Part D primarily covers outpatient retail and self-administered prescriptions.